Bernard W. Futscher, PhD

Professor, Pharmacology and Toxicology
Associate Professor, BIO5, Institute for Collaborative Research 
Assistant Research Scientist, Cancer Center Division
Investigator, Center for Toxicology
Additional Contact Info: 
Fax: (520) 626-2416
  • Loyola University, Chicago, 1990 (Ph.D.)
Honors and Awards: 
NIH R29 First Award
Major Areas of Research Interest: 
  • Molecular mechanisms by which 5-methylcytosine influences structure and function during human carinogenesis.
  • Functional genomics and epigenomics
  • Molecular biology of cancer
  • Cancer pharmacology
Selected Publications: 
Crowley-Weber CL. Payne CM. Gleason-Guzman M. Watts GS. Futscher B. Waltmire CN. Crowley C. Dvorakova K. Bernstein C. Craven M. Garewal H. Bernstein H. Development and molecular characterization of HCT-116 cell lines resistant to the tumor promoter and multiple stress-inducer, deoxycholate. Carcinogenesis. 23(12):2063-80, 2002.
List AF. Spier C. Greer J. Wolff S. Hutter J. Dorr R. Salmon S. Futscher B. Baier M. Dalton W. Phase I/II trial of cyclosporine as a chemotherapy-resistance modifier in acute leukemia. Journal of Clinical Oncology. 11(9):1652-60, 1993.
Micetich KC. Futscher B. Koch D. Fisher RI. Erickson LC. Phase I study of streptozocin- and carmustine-sequenced administration in patients with advanced cancer. Journal of the National Cancer Institute. 84(4):256-60, 1992.
Sponsored Research Through MSRP: 
Megan O'Meara (MSRP 2001, 2002): "Loss of Maspin Expression in Ductal Carcinoma of the Breast."
Advanced Research Distinction Track (RDT): 
Megan O'Meara (Class of 2005): "Loss of Maspin Expression in Ductal Carcinoma in situ of the Breast."
Wednesday, November 18, 2015